GOCOVRI Trademark

Trademark Overview

On Monday, July 20, 2015, a trademark application was filed for GOCOVRI with the United States Patent and Trademark Office. The USPTO has given the GOCOVRI trademark a serial number of 86698587. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, April 22, 2025. This trademark is owned by Adamas Pharmaceuticals, Inc.. The GOCOVRI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the treatment of nervous system disorders
gocovri

General Information

Serial Number86698587
Word MarkGOCOVRI
Filing DateMonday, July 20, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, April 22, 2025
Registration Number5649541
Registration DateTuesday, January 8, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 8, 2015

Trademark Statements

Goods and ServicesPharmaceuticals for the treatment of nervous system disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 24, 2015
Primary Code005
First Use Anywhere DateTuesday, October 24, 2017
First Use In Commerce DateTuesday, October 24, 2017

Trademark Owner History

Party NameADAMAS PHARMA LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressRockville, MD 20850
Party NameADAMAS PHARMA LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressEMERYVILLE, CA 94608
Party NameAdamas Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEmeryville, CA 94608
Party NameAdamas Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEmeryville, CA 94608

Trademark Events

Event DateEvent Description
Monday, August 1, 2016SOU TEAS EXTENSION RECEIVED
Thursday, July 23, 2015NEW APPLICATION ENTERED
Friday, July 24, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 29, 2015ASSIGNED TO EXAMINER
Friday, October 30, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 18, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 8, 2015PUBLISHED FOR OPPOSITION
Tuesday, December 8, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 2, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, July 27, 2017SOU EXTENSION 3 GRANTED
Monday, August 1, 2016SOU EXTENSION 1 FILED
Monday, August 1, 2016SOU EXTENSION 1 GRANTED
Wednesday, August 3, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 23, 2017SOU TEAS EXTENSION RECEIVED
Monday, January 23, 2017SOU EXTENSION 2 FILED
Monday, January 23, 2017SOU EXTENSION 2 GRANTED
Wednesday, January 25, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 27, 2017SOU TEAS EXTENSION RECEIVED
Thursday, July 27, 2017SOU EXTENSION 3 FILED
Friday, August 3, 2018SOU EXTENSION 5 GRANTED
Saturday, July 29, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 31, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, February 1, 2018SOU TEAS EXTENSION RECEIVED
Thursday, February 1, 2018SOU EXTENSION 4 FILED
Thursday, February 1, 2018SOU EXTENSION 4 GRANTED
Saturday, February 3, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 27, 2018SOU TEAS EXTENSION RECEIVED
Friday, July 27, 2018SOU EXTENSION 5 FILED
Friday, August 3, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 18, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, August 4, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 8, 2018TEAS STATEMENT OF USE RECEIVED
Thursday, November 8, 2018USE AMENDMENT FILED
Tuesday, November 13, 2018STATEMENT OF USE PROCESSING COMPLETE
Monday, December 3, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, December 4, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 8, 2019REGISTERED-PRINCIPAL REGISTER
Monday, January 8, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, March 18, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 21, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, April 22, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, April 22, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, March 18, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 18, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 18, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, January 8, 2025TEAS SECTION 8 & 15 RECEIVED

Related Keywords

gocovri disorders system nervous treatment pharmaceuticals